ArticleMethods in molecular biology (Clifton, N.J.)2026
Use of miR-200-Mediated Reprogramming and Mechanical Cues to Generate Human Blastocyst Models.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several early developmental events remain unclear due to ethical and technical limitations related to the use of natural embryos. To overcome this problem, over the last decade, different approaches aimed at the generation of in vitro blastocyst-like models have been developed.Here, we describe a protocol that combines miR-200-mediated cell reprogramming and mechanical stimuli to create 3D spheroids phenotypically similar to natural embryos. Specifically, dermal fibroblasts are reprogrammed exploiting the miR-200 family property to induce a high plasticity state in somatic cells. Subsequently, miR-200-reprogrammed cells are either differentiated into trophoblast (TR)-like cells, using an ad hoc induction protocol, or encapsulated into polytetrafluoroethylene (PTFE) micro-bioreactors to generate inner cell mass (ICM)-like spheroids. Subsequently, TR-like cells and ICM-like spheroids are encapsulated and co-cultured in the same micro-bioreactor and then transferred to microwells to allow further differentiation and boost blastoid development.The generated 3D artificial blastoids, phenotypically similar to natural embryos, could find a useful application in the field of assisted reproduction technologies to further characterize the events taking place during early embryogenesis as well as to study embryo disorders.
Indexed as
Identifiers
40760313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.